Theralase Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA88337V1004
CAD
0.28
0.18 (180.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Perimeter Medical Imaging AI, Inc.
Nanalysis Scientific Corp.
Covalon Technologies Ltd.
Profound Medical Corp.
Spectral Medical, Inc.
Theralase Technologies, Inc.
MedMira, Inc.
Ocumetics Technology Corp.
VentriPoint Diagnostics Ltd.
FuelPositive Corp.
Opsens, Inc.

Why is Theralase Technologies, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Theralase Technologies, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Theralase Technologies, Inc.
-100.0%
0.84
78.39%
S&P/TSX 60
30.34%
2.45
12.36%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.40%
EBIT Growth (5y)
7.52%
EBIT to Interest (avg)
-4.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.59
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
70.57
EV to EBIT
-17.52
EV to EBITDA
-18.63
EV to Capital Employed
63.39
EV to Sales
77.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-361.80%
ROE (Latest)
-398.39%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CAD -2.52 MM

NET PROFIT(HY)

Higher at CAD -1.96 MM

-4What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 1.39 times

RAW MATERIAL COST(Y)

Grown by 12.17% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 21.85 %

Here's what is working for Theralase Technologies, Inc.

Net Profit
Higher at CAD -1.96 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Operating Cash Flow
Highest at CAD -2.52 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Here's what is not working for Theralase Technologies, Inc.

Debtors Turnover Ratio
Lowest at 1.39 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Debt-Equity Ratio
Highest at 21.85 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 12.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales